MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Charles River Laboratories International Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

114.25 2.01

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

111.33

Max

115.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-284M

-214M

Pardavimai

-7.2M

1B

P/E

Sektoriaus vid.

513.35

57.333

Pelnas, tenkantis vienai akcijai

2.66

Pelno marža

-21.32

Darbuotojai

18,700

EBITDA

-296M

-86M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+31.74% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-3.4B

5B

Ankstesnė atidarymo kaina

112.24

Ankstesnė uždarymo kaina

114.25

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Charles River Laboratories International Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2024-08-08 10:30; UTC

Svarbiausios naujienos

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

Akcijų palyginimas

Kainos pokytis

Charles River Laboratories International Inc Prognozė

Kainos tikslas

By TipRanks

31.74% į viršų

12 mėnesių prognozė

Vidutinis 152.5 USD  31.74%

Aukščiausias 188 USD

Žemiausias 100 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Charles River Laboratories International Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

12 ratings

0

Pirkti

12

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

99.95 / 116.06Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.